Abiraterone
NDC 82009-139, Abiraterone acetate, tablet, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-139
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210686
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-139-12 | 82009013912 | 120 TABLET in 1 BOTTLE (82009-139-12) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f5b628b-69da-4a04-a4d5-623b18d1fd5dNADAC price for package 82009013912
GET /v1/drugs/nadac/82009013912
Use it
Look up 82009-139 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.